HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Nucleolar organizer regions in malignant melanoma and melanocytic nevi. Comparison of two counting methods.

Abstract
Using a silver staining technique, we studied nucleolar organizer regions (AgNOR) in paraffin sections of junctional nevi, compound nevi, intradermal nevi, blue nevi, dysplastic nevi, Spitz nevi, lentigo maligna, malignant melanomas in nevus, superficial spreading melanomas, and nodular melanomas. Two methods of counting black dots within nuclei were employed. One method was to count the discrete black dots within the nuclei, including the tiny black dots seen within the nucleolus; the second method did not take into account the subsidiary cluster of tiny black dots seen within the nucleolus, instead treating these dots as a single structure. Whichever method we used, a significant difference was found between the pooled mean AgNOR numbers for benign and malignant lesions. We found an overlap, however, between benign, in particular Spitz and dysplastic nevi, and malignant lesions when considering individual counts of AgNOR using both methods. We conclude that studying AgNOR does not seem to be a useful technique to differentiate Spitz and dysplastic nevi from malignant melanomas.
AuthorsC Di Gregorio, L Losi, G Annessi, A Botticelli
JournalThe American Journal of dermatopathology (Am J Dermatopathol) Vol. 13 Issue 4 Pg. 329-33 (Aug 1991) ISSN: 0193-1091 [Print] UNITED STATES
PMID1928617 (Publication Type: Comparative Study, Journal Article)
Topics
  • Diagnosis, Differential
  • Humans
  • Melanoma (diagnosis, ultrastructure)
  • Nevus, Pigmented (diagnosis, ultrastructure)
  • Nucleolus Organizer Region (ultrastructure)
  • Silver Staining
  • Skin Neoplasms (diagnosis, ultrastructure)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: